Park Avenue Securities LLC Argenx Se Transaction History
Park Avenue Securities LLC
- $9.72 Billion
- Q4 2024
A detailed history of Park Avenue Securities LLC transactions in Argenx Se stock. As of the latest transaction made, Park Avenue Securities LLC holds 1,695 shares of ARGX stock, worth $1.08 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,695
Previous 1,211
39.97%
Holding current value
$1.08 Million
Previous $656,000
58.84%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding ARGX
# of Institutions
404Shares Held
30.8MCall Options Held
376KPut Options Held
489K-
Price T Rowe Associates Inc Baltimore, MD5.82MShares$3.72 Billion0.36% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.51MShares$2.25 Billion2.99% of portfolio
-
Janus Henderson Group PLC London, X02.48MShares$1.59 Billion0.72% of portfolio
-
Capital World Investors Los Angeles, CA1.7MShares$1.09 Billion0.15% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$792 Million10.11% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $35.4B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...